Gunilla Enblad, advisor to Elicera Therapeutics, and Mats Hellström appear in UNT to talk about the CARMA-trial. The article also figures Göran Eriksson, the first patient treated in Elicera's ongoing CARMA-trial, detailing his 25 year journey from cancer diagnosis to being cancer free today.
https://halsoliv.expressen.se/halsa/sjukdomar--besvar-1/goran-58-hjalpt-med--ny-cancerbehandling/